Thus, combining these markers (APRI, GPR, FIB-4, and S-Index) may enhance accuracy in detecting liver fibrosis and cirrhosis, which may reduce the need for liver biopsy in CHB patients. The gene discussed is ALDH18A1; the disease is Hepatic fibrosis.